Evidence map›Paper›PMID 42698040›Full record

ArticleInternational microbiology : the official journal of the Spanish Society for Microbiology2026

In Saccharomyces cerevisiae ΔRIB1 and ΔRIB4 mutants, riboflavin auxotrophy is reverted by Wolbachia (wStr) infection.

Ofelia Mendez-Romero, Carolina Ricardez-García, Salvador Uribe-Carvajal

Abstract read
PubMed Publisher
In one paragraph

Article in International microbiology : the official journal of the Spanish Society for Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ofelia Mendez-RomeroDepartment of Genetics and Molecular Biology, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, CDMX, 04510, México.ORCID http://orcid.org/0000-0002-9246-6128
Carolina Ricardez-GarcíaDepartment of Genetics and Molecular Biology, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, CDMX, 04510, México.ORCID http://orcid.org/0000-0003-0062-8909
Salvador Uribe-CarvajalDepartment of Genetics and Molecular Biology, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, CDMX, 04510, México. suribe@ifc.unam.mx.ORCID http://orcid.org/0000-0002-7028-8121

Funding

DGAPA-PAPIIT IN211224SECIHTI 639365SECIHTI CF-2023-I-199
6 · The paper itself

Abstract

In endosymbiosis, unicellular organisms, mostly prokaryotes, live inside the cells of a host that may be uni- or multicellular. More than half insect and arthropod species host the obligate endosymbiont Wolbachia spp., an alpha-proteobacterium that, given time, may coevolve with its host and progress from parasitism to strict mutualism, where an obligate endosymbiont avoids rejection by providing advantages to the host such as essential nutrients. It was recently found that in the wild yeasts may host both facultative and obligate endosymbionts. To model host-symbiont mutualist interactions in yeast, we tested two different Saccharomyces cerevisiae riboflavin-synthesis pathway deletion mutants (ΔRIB1 and ΔRIB4), finding that these failed to grow in the absence of exogenous riboflavin (RF), i.e., they were RF-auxotrophic strains. In both mutants Wolbachia infection cured auxotrophy. In addition, Wolbachia infection led to a mild increase in survival to exposure to 1 M NaCl or to 10 mM hydrogen peroxide. The artificial yeast/endosymbiont model proposed here may become a useful tool to explore parasitic, facultative and mutualist associations.

Indexed as

EndosymbiosisRiboflavin auxotrophySaccharomyces cerevisiaeWolbachia

Identifiers

PMID42698040

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.